DK0619735T3 - Lyofiliseret præparat, der indeholder S(+)-4,4'-(1-methyl-1,2ethandijyl)-bis(2,6-piperazindion) - Google Patents

Lyofiliseret præparat, der indeholder S(+)-4,4'-(1-methyl-1,2ethandijyl)-bis(2,6-piperazindion)

Info

Publication number
DK0619735T3
DK0619735T3 DK92921457T DK92921457T DK0619735T3 DK 0619735 T3 DK0619735 T3 DK 0619735T3 DK 92921457 T DK92921457 T DK 92921457T DK 92921457 T DK92921457 T DK 92921457T DK 0619735 T3 DK0619735 T3 DK 0619735T3
Authority
DK
Denmark
Prior art keywords
ethanedijyl
bis
methyl
preparation containing
icrf
Prior art date
Application number
DK92921457T
Other languages
English (en)
Inventor
Josephus Johannes Mar Holthuis
Alwinus Antonius Voetman
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10703550&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0619735(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of DK0619735T3 publication Critical patent/DK0619735T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK92921457T 1991-10-25 1992-10-22 Lyofiliseret præparat, der indeholder S(+)-4,4'-(1-methyl-1,2ethandijyl)-bis(2,6-piperazindion) DK0619735T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919122720A GB9122720D0 (en) 1991-10-25 1991-10-25 (s)(+)-4,4'-(1-methyl-1,2-ethanediyl)-bis(2,6-piperazinedione)formulations and their preparation
PCT/EP1992/002400 WO1993007873A1 (en) 1991-10-25 1992-10-22 Lyophilized composition containing s(+)-4,4'-(1-methyl-1,2-ethanediyl)-bis(2,6-piperazinedione)

Publications (1)

Publication Number Publication Date
DK0619735T3 true DK0619735T3 (da) 2000-12-04

Family

ID=10703550

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92921457T DK0619735T3 (da) 1991-10-25 1992-10-22 Lyofiliseret præparat, der indeholder S(+)-4,4'-(1-methyl-1,2ethandijyl)-bis(2,6-piperazindion)

Country Status (11)

Country Link
EP (1) EP0619735B1 (da)
AT (1) ATE193205T1 (da)
AU (1) AU2791292A (da)
DE (1) DE69231098T2 (da)
DK (1) DK0619735T3 (da)
ES (1) ES2145748T3 (da)
GB (1) GB9122720D0 (da)
GR (1) GR3034135T3 (da)
MX (1) MX9206139A (da)
PT (1) PT101007B (da)
WO (1) WO1993007873A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265385B1 (en) * 1996-01-11 2001-07-24 Topo Target Aps Topoisomerase II poison and bis-dioxopiperazine derivative combination therapy
DE60010241T2 (de) 1999-03-12 2005-01-13 Topotarget A/S Dexrazoxan zur behandlung von unerwünschter extravasation von anthrazyklinen
WO2007062076A2 (en) * 2005-11-23 2007-05-31 Novartis Ag Dexrazoxane formulations and methods
CN114306251B (zh) * 2021-12-22 2023-08-11 乐普药业股份有限公司 一种含有右雷佐生的冻干制剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1234935A (en) * 1967-07-03 1971-06-09 Nat Res Dev Piperazine derivatives
US4963551A (en) * 1987-12-21 1990-10-16 Erbamont Inc. Stable lyophilized form of (S)-(+)-bis-4,4'-(1-methyl-1,2-ethanediyl)2,6-piperazinedione and solutions thereof

Also Published As

Publication number Publication date
AU2791292A (en) 1993-05-21
ATE193205T1 (de) 2000-06-15
GR3034135T3 (en) 2000-11-30
MX9206139A (es) 1993-07-01
DE69231098D1 (de) 2000-06-29
WO1993007873A1 (en) 1993-04-29
PT101007A (pt) 1994-01-31
DE69231098T2 (de) 2000-09-14
EP0619735B1 (en) 2000-05-24
EP0619735A1 (en) 1994-10-19
ES2145748T3 (es) 2000-07-16
PT101007B (pt) 1999-07-30
GB9122720D0 (en) 1991-12-11

Similar Documents

Publication Publication Date Title
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE69230610T2 (de) Peptide mit zyklischen Hauptketten, deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
SE8102194L (sv) Terapeutiskt aktiv organisk forening och farmaceutisk beredning innehallande denna
TR199901132T2 (xx) N-(aril/heteoaril) amino asit t�revleri, bunlar� i�eren farmas�tik bile�imler ve b�yle bile�ikler kullan�larak �-amiloid peptidinin sal�nmas�n� ve/veya sentezini inhibe etmek i�in y�ntemler.
GR3006172T3 (da)
FI103408B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaisten valmistamiseksi
DK0410207T3 (da) Stabilisering af højrensede proteiner.
GB1446284A (en) Neurotoxin
ATE144142T1 (de) Verwendung von thiazolidin-4-carboxylatderivaten zur behandlung von lungenerkrankungen
DE69122364T2 (de) Verwendung von (S)-Isofluran und (S)-Desfluran zur Anästhesie sowie entsprechende Arzneimittelzubereitungen
FI854926A (fi) Foerfarande foer framstaellning av farmakologiskt aktiva pyrrolobensimidazoler.
DE3884680D1 (de) Äusseres Membranprotein F von Pseudomonas aeruginosa.
DK0619735T3 (da) Lyofiliseret præparat, der indeholder S(+)-4,4'-(1-methyl-1,2ethandijyl)-bis(2,6-piperazindion)
DE3767308D1 (de) Verwendung von sulfonamidderivaten zur herstellung eines antivirusmittels.
MX9300205A (es) Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene.
KR910005886A (ko) 안정화 백혈구 인터페론
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
ATE82850T1 (de) Verwendung von 2-pyrimidinyl-1-piperazinderivaten.
ATE135364T1 (de) Wasserfreie kristalle von 4-carbamoyl-1-beta-d- ribofuranosyl-imidazolium-5-olat
ATE145197T1 (de) Lagerstabile lösungen von carbonisiertem magnesiumethylat in ethanol sowie deren herstellung und verwendung
ATE190628T1 (de) Zusammensetzungen von wachstumsfaktoren, herstellung und verwendung
FI911961A (fi) Analoger av tillvaexthormon frigoerande faktorer.
DE3880498D1 (de) Verwendung von 5-aminosalicylsaeure (5-asa) zur herstellung einer arzneimittelzubereitung zur verwendung bei einer reperfusionsbehandlung.
FR2425858A1 (fr) Composition ophtalmique pour le traitement de la senescence cristallinienne
RU93004467A (ru) Замещенные пуриновые арабинозы, их применение, фармацевтическая композиция